Tesla China trip fuels speculation on FSD timeline and regulatory path

Tesla has become a focal point for China-related trade and geopolitical positioning, particularly surrounding Elon Musk's visit to Beijing this week during Trump's summit with Xi Jinping. The underlying narrative is that regulatory approval of FSD-equivalent technology in China could accelerate both domestic deployment and provide a blueprint for regulatory pathways in other regions. TSLA moved to $430 recently but has faced headwinds as overbought conditions trigger profit-taking.

Retail traders are positioning heavily on the thesis that "financial news stories about FSD will change tone when they get back," expecting a shift from skepticism to enthusiasm. Some market participants note a pattern in prior Musk media appearances: Ron Baron's CNBC appearances at $267 (down 34% in six months), $170 (up 71% in 12 months), and $340 (up 24% thereafter) suggest the timing of public statements can precede sharp moves. Current positioning at $430 has skeptics watching for a near-term pullback if China talks yield no concrete agreements.

The broader backdrop is that Tesla's profitability remains under pressure from competition in China and price-cutting to maintain volume. Recent technical setups show RSIRelative Strength Index - momentum oscillator on a 0-100 scale. cooling from overbought territory, and some traders view the China trip narrative as a momentumThe empirical fact that winners keep winning over the medium term. story rather than a fundamental catalyst. Concerns that "smoke but never fire" will emerge from negotiations temper bullish conviction.

The counter-narrative remains that autonomous driving is further from commercialization than markets price, and regulatory approval from Beijing does not guarantee profitability or margin expansion for Tesla. Macro headwinds, including slowing China EV market growth and EV pricing deflation, could overwhelm any regulatory wins.